Evidence map›Paper›PMID 36052270›Full record

ArticleDose-response : a publication of International Hormesis Society

Biosorptive Potential of

Riffat Yasmin, Muhammad Shoaib Zafar, Imtiaz Mahmood Tahir, Rizwan Asif, Samra Asghar, Syed Kashif Raza

Abstract read
In one paragraph

Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. PRISMA-based review ofFrontiers in microbiology · 2026
    Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Riffat YasminRiphah College of Rehabilitation and Allied Health Sciences (RCRAHS), Riphah International University, Faisalabad, Pakistan.ORCID https://orcid.org/0000-0002-5754-571X
Muhammad Shoaib ZafarDepartment of Pharmacology, University of Health Sciences, Lahore, Pakistan.ORCID https://orcid.org/0000-0001-8000-6549
Imtiaz Mahmood TahirCollege of Allied Health Professionals, Government College University, Faisalabad, Pakistan.ORCID https://orcid.org/0000-0003-1480-5654
Rizwan AsifDepartment of Eastern Medicine and Surgery, Qarshi University Lahore, Lahore, Pakistan.ORCID https://orcid.org/0000-0002-0061-7233
Samra AsgharRiphah College of Rehabilitation and Allied Health Sciences (RCRAHS), Riphah International University, Faisalabad, Pakistan.
Syed Kashif RazaRiphah College of Rehabilitation and Allied Health Sciences (RCRAHS), Riphah International University, Faisalabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Industrial waste is mainly responsible for accumulating Zn (II) in the soil, which needs to be removed to avoid its bioaccumulation and hazardous effects on the environment. In a recent study, the potential of the RY12 strain was evaluated as a biosorbent of Zn (II) ions in an aqueous medium. Different microbiological techniques like biochemical, molecular characterization, and 16S rRNA gene sequencing were used for the identification of RY12. The impact of different parameters such as the initial zinc ion concentration, pH, temperature, and the removal of other metals such as manganese, lead, cobalt, silver, copper, mercury, and chromium was also evaluated on the reduction of Zn (II). Fourier Transform Infrared spectroscopy (FTIR) was also carried out to investigate the role of cellular surfaces in the sorption of Zn+2 ions. Both biochemical and phylogenetic analyses established that strain RY12 Pseudomonas sp. capable of reducing Zn

Indexed as

bioremediationbiosorptionheavy metal removalindustrial wastewaterPseudomonas sp. RY12Zn (II)

Identifiers

PMID36052270
PMCPMC9425902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.